Pretreatment serum metabolome predicts PFS in first-line trastuzumab-treated metastatic breast cancer Conference

O'Day, Elizabeth, Leitzel, Kim, Ali, Suhail M et al. (2020). Pretreatment serum metabolome predicts PFS in first-line trastuzumab-treated metastatic breast cancer . CANCER RESEARCH, 80(4), 10.1158/1538-7445.SABCS19-P4-10-25

International Collaboration

cited authors

  • O'Day, Elizabeth; Leitzel, Kim; Ali, Suhail M; Zhang, Bo; Dong, Chen; Gu, Haiwei; Shi, Xiajian; Drabick, Joseph J; Cream, Leah; Vasekar, Monali; Polimera, Hyma V; Nagabhairu, Vinod; Moku, Prashanth; Maddukuri, Ashok; Menon, Harry; Pancholy, Neha; Carney, Walter P; Koestler, Wolfgang; Lipton, Allan

authors

date/time interval

  • December 9, 2019 -

publication date

  • February 1, 2020

webpage

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Location

  • San Antonio, TX

Digital Object Identifier (DOI)

Conference

  • 42nd Annual San Antonio Breast Cancer Symposium

publisher

  • AMER ASSOC CANCER RESEARCH

volume

  • 80

issue

  • 4